Araujo Jéssica, Monteiro Joveliane, Silva Douglas, Alencar Amanda, Silva Kariny, Coelho Lara, Pacheco Wallace, Silva Darlan, Silva Maria, Silva Luís, Monteiro Andrea
Rede de Biodiversidade e Biotecnologia da Amazônia Legal, BIONORTE, São Luís 65055-310, MA, Brazil.
Laboratório de Microbiologia Aplicada, Universidade CEUMA, São Luís 65075-120, MA, Brazil.
Antibiotics (Basel). 2022 Aug 16;11(8):1106. doi: 10.3390/antibiotics11081106.
Surface-active compounds (SACs), biomolecules produced by bacteria, yeasts, and filamentous fungi, have interesting properties, such as the ability to interact with surfaces as well as hydrophobic or hydrophilic interfaces. Because of their advantages over other compounds, such as biodegradability, low toxicity, antimicrobial, and healing properties, SACs are attractive targets for research in various applications in medicine. As a result, a growing number of properties related to SAC production have been the subject of scientific research during the past decade, searching for potential future applications in biomedical, pharmaceutical, and therapeutic fields. This review aims to provide a comprehensive understanding of the potential of biosurfactants and emulsifiers as antimicrobials, modulators of virulence factors, anticancer agents, and wound healing agents in the field of biotechnology and biomedicine, to meet the increasing demand for safer medical and pharmacological therapies.
表面活性化合物(SACs)是细菌、酵母和丝状真菌产生的生物分子,具有有趣的特性,例如能够与表面以及疏水或亲水界面相互作用。由于它们相对于其他化合物具有优势,如生物可降解性、低毒性、抗菌和愈合特性,SACs是医学各种应用研究的有吸引力的目标。因此,在过去十年中,越来越多与SAC生产相关的特性成为科学研究的主题,以寻找在生物医学、制药和治疗领域的潜在未来应用。本综述旨在全面了解生物表面活性剂和乳化剂作为生物技术和生物医学领域中的抗菌剂、毒力因子调节剂、抗癌剂和伤口愈合剂的潜力,以满足对更安全的医学和药理学疗法日益增长的需求。